Biodexa Pharmaceuticals Plc (NASDAQ:BDRX – Get Free Report) saw a large decline in short interest in August. As of August 31st, there was short interest totalling 85,900 shares, a decline of 17.7% from the August 15th total of 104,400 shares. Based on an average daily trading volume, of 1,450,000 shares, the short-interest ratio is currently 0.1 days.
Biodexa Pharmaceuticals Stock Down 4.8 %
Shares of BDRX stock opened at $0.38 on Wednesday. Biodexa Pharmaceuticals has a twelve month low of $0.35 and a twelve month high of $8.81. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.26 and a current ratio of 1.26. The business has a fifty day simple moving average of $0.65 and a 200 day simple moving average of $0.92.
About Biodexa Pharmaceuticals
See Also
- Five stocks we like better than Biodexa Pharmaceuticals
- Why is the Ex-Dividend Date Significant to Investors?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- 3 Best Fintech Stocks for a Portfolio Boost
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- How to Evaluate a Stock Before BuyingÂ
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.